Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diarra-Mehrpour, M.
Right arrow Articles by Chouaib, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diarra-Mehrpour, M.
Right arrow Articles by Chouaib, S.
[Cancer Research 64, 719-727, January 15, 2004]
© 2004 American Association for Cancer Research


Regular Articles

Prion Protein Prevents Human Breast Carcinoma Cell Line from Tumor Necrosis Factor {alpha}-Induced Cell Death

Maryam Diarra-Mehrpour1, Samuel Arrabal25, Abdelali Jalil1, Xavier Pinson1, Catherine Gaudin1, Geneviève Piétu3, Amandine Pitaval3, Hugues Ripoche4, Marc Eloit2, Dominique Dormont5 and Salem Chouaib1

1 Laboratoire de Cytokines et Immunologie des Tumeurs Humaines, Institut National de la Santé et de la Recherche Médicale U-487, Institut Gustave Roussy Pavillon de Recherche 1 and Institut Fédératif de Recherche, Villejuif, France;
2 Unité Mixte de Recherche 1161 de Virologie Institut National de Recherche Agronomique Agence Française de Sécurité Sanitaire des Aliments École National Vétérinaire d’Alfort, Maisons Alfort, France;
3 Commisariat à l’Énergie Atomique, Service de Génomique Fonctionnelle, Evry, France;
4 Unité Mixte de Recherche 8125 Centre National de la Recherche Scientifique, Institut Gustave Roussy Pavillon de Recherche 2, Villejuif, France; and
5 Commisariat à l’Énergie Atomique, Service de Neurovirologie, Centre de Recherche du Service Santé des Armés, École Pratique des Hautes Études, Institut Paris sud sur les Cytokines, Université Paris XI, Fontenay-aux-Roses, France

To define genetic determinants of tumor cell resistance to the cytotoxic action of tumor necrosis factor {alpha} (TNF), we have applied cDNA microarrays to a human breast carcinoma TNF-sensitive MCF7 cell line and its established TNF-resistant clone. Of a total of 5760 samples of cDNA examined, 3.6% were found to be differentially expressed in TNF-resistant 1001 cells as compared with TNF-sensitive MCF7 cells. On the basis of available literature data, the striking finding is the association of some differentially expressed genes involved in the phosphatidylinositol-3-kinase/Akt signaling pathway. More notably, we found that the PRNP gene coding for the cellular prion protein (PrPc), was 17-fold overexpressed in the 1001 cell line as compared with the MCF7 cell line. This differential expression was confirmed at the cell surface by immunostaining that indicated that PrPc is overexpressed at both mRNA and protein levels in the TNF-resistant derivative. Using recombinant adenoviruses expressing the human PrPc, our data demonstrate that PrPc overexpression converted TNF-sensitive MCF7 cells into TNF-resistant cells, at least in part, by a mechanism involving alteration of cytochrome c release from mitochondria and nuclear condensation.




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
R. Linden, V. R. Martins, M. A. M. Prado, M. Cammarota, I. Izquierdo, and R. R. Brentani
Physiology of the Prion Protein
Physiol Rev, April 1, 2008; 88(2): 673 - 728.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Meslin, A. Hamai, P. Gao, A. Jalil, N. Cahuzac, S. Chouaib, and M. Mehrpour
Silencing of Prion Protein Sensitizes Breast Adriamycin-Resistant Carcinoma Cells to TRAIL-Mediated Cell Death
Cancer Res., November 15, 2007; 67(22): 10910 - 10919.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
F. Meslin, R. Conforti, C. Mazouni, N. Morel, G. Tomasic, F. Drusch, M. Yacoub, J. C. Sabourin, J. Grassi, S. Delaloge, et al.
Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancer
Ann. Onc., November 1, 2007; 18(11): 1793 - 1798.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
K.-J. Lee, A. Panzera, D. Rogawski, L. E. Greene, and E. Eisenberg
Cellular prion protein (PrPC) protects neuronal cells from the effect of huntingtin aggregation
J. Cell Sci., August 1, 2007; 120(15): 2663 - 2671.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. Liang, Y. Pan, D. Zhang, C. Guo, Y. Shi, J. Wang, Y. Chen, X. Wang, J. Liu, X. Guo, et al.
Cellular prion protein promotes proliferation and G1/S transition of human gastric cancer cells SGC7901 and AGS
FASEB J, July 1, 2007; 21(9): 2247 - 2256.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Jodoin, S. Laroche-Pierre, C. G. Goodyer, and A. C. LeBlanc
Defective Retrotranslocation Causes Loss of Anti-Bax Function in Human Familial Prion Protein Mutants
J. Neurosci., May 9, 2007; 27(19): 5081 - 5091.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Li, S. J. Barmada, K. A. Roth, and D. A. Harris
N-Terminally Deleted Forms of the Prion Protein Activate Both Bax-Dependent and Bax-Independent Neurotoxic Pathways
J. Neurosci., January 24, 2007; 27(4): 852 - 859.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Sunyach, M. A. Cisse, C. A. da Costa, B. Vincent, and F. Checler
The C-terminal Products of Cellular Prion Protein Processing, C1 and C2, Exert Distinct Influence on p53-dependent Staurosporine-induced Caspase-3 Activation
J. Biol. Chem., January 19, 2007; 282(3): 1956 - 1963.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
Y. Pan, L. Zhao, J. Liang, J. Liu, Y. Shi, N. Liu, G. Zhang, H. Jin, J. Gao, H. Xie, et al.
Cellular prion protein promotes invasion and metastasis of gastric cancer
FASEB J, September 1, 2006; 20(11): 1886 - 1888.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Li and D. A. Harris
Mammalian Prion Protein Suppresses Bax-induced Cell Death in Yeast
J. Biol. Chem., April 29, 2005; 280(17): 17430 - 17434.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Drisaldi, J. Coomaraswamy, P. Mastrangelo, B. Strome, J. Yang, J. C. Watts, M. A. Chishti, M. Marvi, O. Windl, R. Ahrens, et al.
Genetic Mapping of Activity Determinants within Cellular Prion Proteins: N-TERMINAL MODULES IN PrPC OFFSET PRO-APOPTOTIC ACTIVITY OF THE DOPPEL HELIX B/B' REGION
J. Biol. Chem., December 31, 2004; 279(53): 55443 - 55454.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.